BAFS - Overview: Bile Acids, Fractionated and Total, Serum

Test Catalog

Test Name

Test ID: BAFS    
Bile Acids, Fractionated and Total, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Measurement of tauro- and glycol-conjugated and unconjugated bile acid constituents in serum


Monitoring patients receiving bile acid therapy, such as cholic acid, deoxycholic acid, or ursodeoxycholic acid


Aiding in the evaluation of liver function; evaluation of liver function changes before the formation of more advanced clinical signs of illness such as icterus


Determining hepatic dysfunction as a result of chemical and environmental injury


Indication of hepatic histological improvement in chronic hepatitis C patients responding to interferon treatment


Indication of intrahepatic cholestasis of pregnancy


Bile acids are elevated in individuals with liver dysfunction.


This bile acid test can be used in the diagnosis of intrahepatic cholestasis of pregnancy.


Fractionated bile acids, including tauro- and glycol-conjugates of cholic acid, chenodeoxycholic acid, deoxycholic acid, and ursodeoxycholic acid are individually summed and reported.

Special Instructions and Forms Library of PDFs including pertinent information and consent forms, specimen collection and preparation information, test algorithms, and other information pertinent to test

Method Name A short description of the method used to perform the test

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Bile Acids, Fractionated and Tot, S

Aliases Lists additional common names for a test, as an aid in searching

Bile Acid